Warning: This episode contains descriptions of violence.The relationship between two democratic allies fell to its lowest point in history this week, after Canada accused India of assassinating a Sikh community leader in British Columbia in June.Mujib Mashal, The Times’s South Asia bureau chief, explains this stunning accusation — and what India’s reaction to it tells us about the era of its leader, Narendra Modi.Guest: Mujib Mashal, The New York Times’s bureau chief for South Asia.Background reading: Prime Minister Justin Trudeau of Canada said agents of India had assassinated a Sikh community leader, Hardeep Singh Nijjar, who was fatally shot in British Columbia in June.Mr. Nijar was a prominent advocate of the creation of an independent Sikh nation that would include parts of India’s Punjab State.The charge, which the Indian government has strongly rejected, may fuel a rift between Canada’s Sikhs and Hindus.For more information on today’s episode, visit nytimes.com/thedaily. Transcripts of each episode will be made available by the next workday.

New research and polling show that more and more Americans now doubt a previously unquestioned fact of U.S. life — that going to college is worth it.Paul Tough, a contributing writer for The New York Times Magazine, explains why so many high-school students and their parents are souring on higher education and what it will mean for the country’s future.Guest: Paul Tough, a contributing writer for The New York Times Magazine who has written several books on inequality in education.Background reading: Americans are losing faith in the value of college. Whose fault is that?In December, Colby-Sawyer in New Hampshire reduced its tuition to $17,500 a year, from about $46,000. The cut was a recognition that few pay the list price.For more information on today’s episode, visit nytimes.com/thedaily. Transcripts of each episode will be made available by the next workday.

As Ukraine’s counteroffensive grinds on, it’s increasingly turning to a secret drone program that is hitting targets deep inside Russian territory. At least three different Ukrainian-made drones have been used in attacks inside Russia, including on Moscow, according to an analysis by The New York Times.Christiaan Triebert, a journalist on The Times’s Visual Investigations team, explains the origins of that program. We also speak to Serhiy Prytula, a former Ukrainian television host who is now a key force behind it.Guest: Christiaan Triebert, a journalist on The New York Times’s Visual Investigations team.Background reading: Officials in Ukraine rarely discuss attacks on targets inside Russia, including Moscow. But video evidence shows an increasing effort to launch long-range strikes inside the country.Moscow said Ukraine used drones to strike Novorossiysk, a Black Sea naval and shipping hub, and a port in occupied Crimea.For more information on today’s episode, visit nytimes.com/thedaily. Transcripts of each episode will be made available by the next workday.

Drugs like Ozempic are revolutionizing the treatment of obesity. The medications, originally used to treat diabetes, keep gaining attention as celebrities and other influencers describe taking them to lose weight quickly.Dani Blum, a reporter for The Times, tells the story behind the drugs and describes some of the ramifications of using them.Guest: Dani Blum, a reporter for Well at The New York Times.Background reading: Ozempic can cause major weight loss. What happens if you stop taking it?Some people taking the drugs can experience such intense lack of appetite that they become malnourished.For more information on today’s episode, visit nytimes.com/thedaily. Transcripts of each episode will be made available by the next workday.

Twenty years ago, a glamorous platinum-blond widow arrived at the Paris law office of Claude Dumont Beghi in tears. Someone was trying to take her horses — her “babies” — away, and she needed a lawyer to stop them.She explained that her late husband had been a breeder of champion thoroughbreds. The couple was a familiar sight at the racetracks in Chantilly and Paris: Daniel Wildenstein, gray-suited with a cane in the stands, and Sylvia Roth Wildenstein, a former model with a cigarette dangling from her lips. They first met in 1964, while she was walking couture shows in Paris and he was languishing in a marriage of convenience to a woman from another wealthy Jewish family of art collectors. Daniel, 16 years Sylvia’s senior, already had two grown sons when they met, and he didn’t want more children. So over the next 40 years they spent together, Sylvia cared for the horses as if they were the children she never had. When Daniel died of cancer in 2001, he left her a small stable.Then, one morning about a year later, Sylvia’s phone rang. It was her horse trainer calling to say that he had spotted something odd in the local racing paper, Paris Turf: The results of Sylvia’s stable were no longer listed under her name. The French journalist Magali Serre’s 2013 book “Les Wildenstein” recounts the scene in great detail: Sylvia ran to fetch her copy and flipped to the page. Sure enough, the stable of “Madame Wildenstein” had been replaced by “Dayton Limited,” an Irish company owned by her stepsons.This story was recorded by Audm. To hear more audio stories from publications like The New York Times, download Audm for iPhone or Android.